Florida Issues Urgent Warning on 7-Hydroxymitragynine: What Families Need to Know About This Potent Opioid-Like Compound

The Florida Department of Health issued an urgent warning on June 16, 2026, about a dangerous opioid-like compound appearing in stores across the state. 7-hydroxymitragynine (7-OH) and its derivatives are being marketed and sold in gas stations, convenience stores, and vape shops—often in candy-like packaging that can be easily mistaken for harmless supplements or treats.

This alert is particularly important for families concerned about substance use, as these products are unregulated, potentially addictive, and carry significant health risks that many consumers do not understand.

What Is 7-Hydroxymitragynine?

7-hydroxymitragynine (7-OH) is a potent compound derived from the kratom plant (Mitragyna speciosa), a tree native to Southeast Asia. While natural kratom leaves have been used traditionally for centuries, 7-OH is different—it is a highly concentrated, chemically manipulated form that acts as a powerful opioid partial agonist.

The key distinction families should understand: natural kratom leaf contains only trace amounts of 7-OH. However, modern manufacturing processes chemically convert mitragynine (the primary compound in kratom) into concentrated 7-OH, creating products with pharmacological profiles dramatically different from the natural plant. These concentrated products bind to opioid receptors in the brain, producing effects similar to prescription opioids and carrying comparable risks of dependence and overdose.

Why Florida Issued This Warning Now

Florida health officials took action because 7-OH products have become increasingly available throughout the state, often sold with minimal labeling and little to no consumer education about their risks. The products appear in various forms:

• Tablets and capsules
• Liquid extracts
• Powdered formulations
• Edible products resembling candy or snacks

The packaging often emphasizes "natural" ingredients or wellness benefits while downplaying or omitting the opioid-like effects and potential for addiction. This marketing approach is particularly concerning because it may attract younger users or individuals seeking alternatives to prescription medications who do not realize they are consuming a potent psychoactive substance.

Clinical Risks and Health Consequences

7-OH produces effects similar to other opioids, including pain relief, sedation, and euphoria. However, these effects come with significant clinical risks:

Respiratory Depression: Like other opioids, 7-OH can slow breathing. At higher doses, this effect can become life-threatening, particularly when combined with other substances that depress the central nervous system.

Addiction and Dependence: Regular use of 7-OH can lead to physical dependence. Users who stop abruptly may experience withdrawal symptoms including anxiety, irritability, muscle aches, insomnia, and cravings—similar to opioid withdrawal.

Variable Potency: Because these products are unregulated, the actual 7-OH content can vary dramatically between products and batches. A dose that produced mild effects one day could cause significant impairment or overdose the next.

Drug Interactions: 7-OH can interact dangerously with prescription medications, alcohol, benzodiazepines, and other central nervous system depressants, increasing the risk of respiratory depression and overdose.

Limited Medical Oversight: Unlike prescription opioids, which are dispensed with warnings, dosing instructions, and physician oversight, 7-OH products provide none of these safeguards.

What Families Should Know and Do

If you have family members who shop at gas stations, convenience stores, or vape shops—or if you are concerned about substance use in your household—here are practical steps to take:

Recognize the Products: 7-OH may appear on labels as "7-hydroxymitragynine," "7-OH," or be included in products marketed as "enhanced kratom" or "kratom extracts." Be wary of any supplement sold in tablet or liquid form at non-pharmacy retail locations promising pain relief, relaxation, or mood enhancement.

Have Direct Conversations: Talk with family members, particularly young adults and teenagers, about the risks of unregulated substances sold in stores. Emphasize that "natural" does not mean safe, and that products sold legally can still carry significant health risks.

Secure Your Home: If anyone in your household uses kratom products, consider whether 7-OH-containing products may be present. Store any substances securely and have open conversations about what is being consumed.

Know the Signs of Trouble: Watch for signs of opioid use, including:

• Unusual drowsiness or sedation
• Constricted pupils
• Changes in mood or behavior
• Secretive behavior regarding supplements or substances
• Withdrawal symptoms when not using the product

Seek Professional Guidance: If a family member is using 7-OH products regularly or experiencing withdrawal symptoms, consult a healthcare provider or addiction specialist. Treatment options are available, and early intervention can prevent progression to more severe substance use disorders.

Regulatory Context and Federal Response

Florida has taken a proactive stance on 7-OH regulation. In August 2025, the state issued an emergency rule classifying concentrated 7-OH products as Schedule I controlled substances—placing them in the same regulatory category as heroin and LSD under state law. This classification makes possession, sale, and distribution illegal within Florida.

The U.S. Food and Drug Administration has also identified 7-OH as a public health concern. FDA officials have stated they are working to establish a "strong, scientifically grounded regulatory framework" targeting dangerous synthetic and artificially concentrated products. The Drug Enforcement Administration is collaborating with HHS on federal scheduling decisions.

However, regulatory processes take time, and during this period of transition, these products remain available in many jurisdictions. The Florida warning underscores that even where state restrictions exist, enforcement challenges and interstate commerce mean products may still appear in retail environments.

Where to Get Help

If you or someone you know is struggling with substance use involving 7-OH or any other substance, resources are available:

SAMHSA National Helpline: 1-800-662-HELP (4357)
Free, confidential, 24/7 treatment referral and information service available in English and Spanish.

Florida Poison Control Centers: 1-800-222-1222
If you suspect poisoning or overdose, call immediately. Available 24/7.

Emergency Services: Call 911 if someone shows signs of overdose, including:

• Slow or stopped breathing
• Extreme drowsiness or unresponsiveness
• Bluish lips or fingernails
• Pinpoint pupils

Treatment Locator: SAMHSA's treatment locator can help you find addiction treatment providers in your area, including programs that specialize in opioid use disorder.

The Bottom Line

The Florida Department of Health's warning about 7-hydroxymitragynine highlights an ongoing challenge in the evolving landscape of substance use: new compounds with significant health risks can appear in mainstream retail environments faster than regulatory systems can respond. For families, awareness and open communication remain the most effective tools for protection.

If you have concerns about 7-OH or other substances, do not hesitate to reach out to healthcare providers, addiction specialists, or the resources listed above. Early intervention and honest conversation can make a significant difference in preventing substance use disorders and supporting recovery.

This alert was medically reviewed by Dr. Rachel Bennett, MD, a board-certified addiction medicine physician. The information provided is for educational purposes and should not replace professional medical advice. If you are experiencing a medical emergency, call 911 immediately.